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Antibodies readily neutralize acute, epidemic viruses, but are less effective against more indolent
pathogens such as herpesviruses. Murid herpesvirus 4 (MuHV-4) provides an accessible model
for tracking the fate of antibody-exposed gammaherpesvirus virions. Glycoprotein L (gL) plays a
central role in MuHV-4 entry: it allows gH to bind heparan sulfate and regulates fusion-associated
conformation changes in gH and gB. However, gL is non-essential: heparan sulfate binding can
also occur via gp70, and the gB–gH complex alone seems to be sufficient for membrane fusion.
Here, we investigated how gL affects the susceptibility of MuHV-4 to neutralization. Immune sera
neutralized gL
” virions more readily than gL
+ virions, chiefly because heparan sulfate binding now
depended on gp70 and was therefore easier to block. However, there were also post-binding
effects. First, the downstream, gL-independent conformation of gH became a neutralization
target; gL normally prevents this by holding gH in an antigenically distinct heterodimer until after
endocytosis. Second, gL
” virions were more vulnerable to gB-directed neutralization. This
covered multiple epitopes and thus seemed to reflect a general opening up of the gH–gB entry
complex, which gL again normally restricts to late endosomes. gL therefore limits MuHV-4
neutralization by providing redundancy in cell binding and by keeping key elements of the virion
fusion machinery hidden until after endocytosis.
INTRODUCTION
Most vaccines depend on eliciting neutralizing antibodies
(Zinkernagel & Hengartner, 2006). Herpesvirus carriers
remain infectious despite making antibody responses.
Preventing herpesvirus infections by vaccination is there-
fore a difficult challenge. We are using murid herpesvirus 4
(MuHV-4) to understand gammaherpesvirus neutraliza-
tion. MuHV-4 binds to cells via heparan sulfate, using
either gp70, a product of ORF4 (Gillet et al., 2007a), or
gH–gL (Gillet et al., 2008a). Immune sera can block cell
binding (Gill et al., 2006), but they block membrane fusion
poorly, allowing opsonized virions to infect macrophages
and dendritic cells via IgG Fc receptors (Rosa et al., 2007).
Bypassing cell-binding blocks in this way is not unique to
MuHV-4 (Inada et al., 1985; Maidji et al., 2006).
How might herpesvirus membrane fusion be blocked
better? Answering this means understanding how fusion
works. Virus-specific glycoproteins, such as herpes simplex
virus gD, can modulate fusion (Avitabile et al., 2007;
Atanasiu et al., 2007) and some herpesviruses can express
alternative fusion complexes by using different accessory
glycoproteins (Borza & Hutt-Fletcher, 2002; Wang &
Shenk, 2005), but the core machinery, comprising the
gH–gL heterodimer and gB (Browne et al., 2001), is
conserved. MuHV-4 membrane fusion is pH-dependent
and occurs in late endosomes (Gillet et al., 2008b). Fusion
is associated with conformation changes in both gH and gB
(Gillet et al., 2008b, c). gB probably switches between pre-
and post-fusion states, like the structurally homologous
vesicular stomatitis virus glycoprotein G (Roche et al.,
2007), but gH is different. It switches from a gL-dependent
to a gL-independent conformation in late endosomes
(Gillet et al., 2008c), implying that gH and gL dissociate.
Yet gL
2 virions, which constitutively express the down-
stream form of gH (‘gH-only’), remain infectious; indeed,
they show premature rather than impaired membrane
fusion (Gillet et al., 2008c). It therefore appears that gH
changes from gH–gL to gH-only before engaging in fusion.
Not only is gH different in gL
2 virions: gB also shows
conformational instability. This is consistent with a knock-
on effect of the change in gH, as gH–gL and gB are
associated in the virion membrane (Gillet & Stevenson,
2007a). A link – probably intramembrane – is maintained
between gH and gB, even without gL (Gillet & Stevenson,
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the gH–gL and gH-only conformations are antigenically
very different (Gill et al., 2006). The gB N terminus covers
part of gH–gL, and deleting it also seems to destabilize gB
(Gillet & Stevenson, 2007b). This region may therefore
bridge the gB and gH–gL extracellular domains.
The gB and gH conformation changes present problems for
antibodies that would block membrane fusion (Gill et al.,
2006; Gillet et al., 2006). First, antibodies must act
indirectly, either by blocking conformation changes
(probably the major mechanism for gH–gL) or by causing
steric hindrance (probably the major mechanism for gB)
(Gillet et al., 2008b). Second, they must remain attached to
their targets in late endosomes and compete with
conformation changes that are energetically favourable at
low pH. With glycan shielding (Gillet & Stevenson, 2007b)
and poor immunogenicity (Gillet et al., 2007b) also
factored in, it is perhaps unsurprising that complete
MuHV-4 neutralization is so hard.
ThecentralrolesofgLinMuHV-4cellbindingandmembrane
fusion suggest an additional role for it in virion neutralization.
Whether gL itself is a neutralization target is unknown, but
gH–gL is the major mAb-defined target on wild-type virions
(Gill et al., 2006). This neutralization operates downstream of
cell binding, presumably by inhibiting the post-endocytic
dissociation of gL from gH. Disrupting gL would remove gH–
gL as a target, but could instead reveal other gH epitopes. In
order to understand how gL affects neutralization, we
compared the infectivity of gL
+ and gL
2 virions after
exposure to immune sera or mAbs. Our results explain some
o ft h er e s i s t a n c eo fw i l d - t y p eMuHV-4 virions to neutraliza-
tion and shed new light on herpesvirus entry.
METHODS
Mice, sera and mAbs. Female C57BL/6 or BALB/c mice (Harlan
UK) were infected intranasally with MuHV-4 when 6–8 weeks old, in
accordance with local ethics and Home Office Project Licence 80/
1992. Immune sera were collected and mAbs were derived at least
3 months later. For the latter, spleen cells were taken 3 days after an
intraperitoneal virus boost and fused to NS0 myeloma cells (Ko ¨hler &
Milstein, 1975). Hybrids were selected with azaserine and typed for
virion glycoprotein recognition (Gillet et al., 2007b). Antibodies were
concentrated by ammonium sulfate precipitation, dialysed against
PBS, isotyped by ELISA (Sigma) and quantified by Mancini assay
(Mancini et al., 1965). They are listed in Table 1.
Cells and viruses. BHK-21 fibroblasts (ATCC CCL-10), NMuMG
epithelial cells (ATCC CRL-1636), RAW-264 macrophages (ATCC
TIB-71), 293T cells (ATCC CRL-11268), CHO–gH cells (Gill et al.,
2006) and CHO–gp70 cells (Gillet et al., 2007a) were grown in
Dulbecco’s modified Eagle’s medium (DMEM) with 2 mM gluta-
mine, 100 U penicillin ml
21, 100 mg streptomycin ml
21 and 10%
fetal calf serum. NS0 cells and the hybridomas derived from them
were grown in RPMI medium, supplemented as for DMEM. MuHV-4
was propagated in BHK-21 cells (de Lima et al., 2004). Cell debris was
removed by low-speed centrifugation (1000 g, 10 min) and virions
were recovered from supernatants by high-speed centrifugation
(38000 g, 90 min). gp70
2 (Gillet et al., 2007a), gL
2 (Gillet et al.,
2007c, 2008c) and gM–enhanced green fluorescent protein (eGFP)-
tagged (Gillet et al., 2006) MuHV-4 mutants have been described
previously. The gL
2STOP, gL
2DEL and gL
2DEL-STOP mutants
used here are all phenotypically equivalent. 293T cells were
transfected with expression plasmids for glycosylphosphatidylinositol
(GPI)-linked forms of gH, gL and gH–gL (Gill et al., 2006; Gillet et al.,
2008a) by using Fugene-6 (Roche Diagnostics).
Virus titres and neutralization assays. MuHV-4 was titrated by
plaque assay (de Lima et al., 2004). After incubation with virus (2 h,
37 uC), BHK-21 cell monolayers were overlaid with 0.3% carboxy-
methylcellulose and 4 days later fixed and stained in 4% formalde-
hyde/0.1% toluidine blue. Viruses with an eGFP expression cassette
(Adler et al., 2000) were alternatively titrated by eGFP expression. Cells
were exposed to virus overnight in phosphonoacetic acid (100 mg
ml
21) to prevent infection spreading. RAW-264 cells were further
treated with LPS (6 h, 100 ng ml
21) to activate the eGFP expression
cassette maximally (Rosa et al., 2007). The proportion of infected cells
in each culture was determined by flow cytometry. BHK-21 or
NMuMG cellswereinfected at0.1–0.3p.f.u. percellandRAW-264cells
at 1–3 p.f.u. per cell to give 20–60% eGFP
+ cells, eGFP titres being
typically 2-fold higher than plaque titres for BHK-21 cells and 10-fold
higher for BHK-21 than for RAW-264 cells. Virus titres were calculated
by assuming each eGFP
+ cell to be a single hit. For neutralization,
viruses were incubated with dilutions of serum or mAb (2 h, 37 uC)
before being added to the cells and assayed for infectivity as above. All
sera were pooled from at least three mice. The sera within each
experiment were equivalent in ELISA titre for IgG binding to Triton
X-100-disrupted virions (Stevenson & Doherty, 1999).
Immunofluorescence. MuHV-4 virions (3 p.f.u. per cell) were
exposed or not to antibody (2 h, 37 uC) then bound to cells on glass
coverslips (2 h, 4 uC). The cells were then washed three times in PBS
to remove unbound virions, and shifted to 37 uC to allow
endocytosis. After incubation at 37 uC, the cells were fixed in 4%
paraformaldehyde (30 min), permeabilized with 0.1% Triton X-100
(15 min) and stained with virus-specific mAbs plus Alexa 488-
conjugated goat anti-mouse IgG1 (Invitrogen) and Alexa 568-
conjugated goat anti-mouse IgG2a. Nuclei were counterstained with
DAPI (4,6-diamidino-2-phenylindole). Fluorescence was visualized
with a Leica SP2 confocal microscope and analysed with ImageJ.
None of the mAbs stained uninfected cells detectably.
Flow cytometry. Transfected or MuHV-4-infected cells (2 p.f.u. per
cell, 18 h) were trypsinized, washed in PBS and incubated (1 h, 4 uC)
with MuHV-4-glycoprotein-specific mAbs, followed by fluorescein-
conjugated rabbit anti-mouse IgG pAb (Dako Cytomation) or Alexa
633-conjugated goat anti-mouse IgG (Invitrogen). The cells were
washed in PBS after each incubation and analysed on a FACScalibur
(BD Biosciences).
Immunoblotting. Virions were lysed and denatured by heating
(95 uC, 5 min) in Laemmli’s buffer, resolved by SDS-PAGE and
transferred to PVDF membranes. The membranes were probed with
the ORF17 capsid antigen-specific mAb 150-7D1 plus horseradish
peroxidase-conjugated rabbit anti-mouse IgG pAb (Dako
Cytomation), followed by ECL substrate development (Amersham
Pharmacia Biotech).
RESULTS
A lack of gL increases MuHV-4 susceptibility to
neutralization by immune sera
We first compared the susceptibility of gL
+ and gL
2
virions to neutralization by sera from mice infected with
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2 virions were consistently
more susceptible than gL
+ virions. This applied to
independently derived mutants and not to a gL
+ revertant
(Fig. 1b). gL
2 mutants were also more susceptible to
neutralization by sera from mice infected with gL
2 MuHV-
4 (Fig. 1c).
The greater neutralization of gL
” MuHV-4
depends largely on antibodies to gp70
MuHV-4 binds to heparan sulfate via gH–gL or gp70. gL
2
virions can only bind via gp70, so a possible explanation
for their greater susceptibility to neutralization was that
immune sera more readily blocked cell binding. We tested
this by neutralizing wild-type, gL
2 or gp70
2 virions with
sera from wild-type-immune, gL
2-immune or gp70
2-
immune mice (Fig. 2). Sera from mice infected with
knockout viruses should selectively lack antibodies against
the knocked out gene product. All sera were pooled from at
least three mice and had equivalent ELISA titres for
detergent-disrupted wild-type virions.
We know from hybridoma analysis that even pooled mice
show quite different neutralizing-antibody responses.
However, the basic hierarchy between different viruses
and sera was very reproducible: the neutralizations of gL
2
virions by gp70
2-immune sera and of gp70
2 virions by
gL
2-immune sera were consistently poor, and eight out of
Table 1. MuHV-4-specific mAbs
mAb Target Isotype Reference Neutralization*
gL
” gL
+
T1G10 gp70 SCR1 IgG2a Gill et al. (2006) +++ 2
T2B11 gp70 SCR1 IgM Gillet et al. (2007a) +++ 2
LT-6E8 gp70 SCR2 IgG2b Gillet et al. (2008a) +++ 2
LT-1E3 gp70 SCR3 IgG1 This paper 22
T3B8 gp70 SCR4 IgG1 Gillet et al. (2007a) 22
58-16D2 gp70 SCR4 IgG2a Gillet et al. (2007a) 22
LT-4D11 gp70 SCR4 IgG2a This paper 22
230-4A2 gH–gL IgG2a Gillet et al. (2008a) 2 +
8F10 gH–gL IgG2a Gillet et al. (2008a) 2 +
7E5 gH–gL IgG2a Gill et al. (2006) 2 ++
7D6 gH–gL IgG2a Gill et al. (2006) 2 ++
T7G7 gH–gL IgG2a Gill et al. (2006) 2 ++
T2C12 gH–gL IgG2a Gill et al. (2006) 2 ++
GB-6E11 gH–gL IgG2b This paper 2 ++
MG-1A2 gH-only IgG1 Gillet et al. (2007d) ++ 2
MG-2E6 gH-only IgG2a Gillet et al. (2007d) ++ 2
MG-9A3 gH-only IgG2a Gillet et al. (2007d) ++ 2
MG-9B10 gH-only IgG2b Gillet et al. (2007d) ++ 2
MG-4A12 gH-only IgG2a This paper ++ 2
LT-5D3 gH-only IgG2a This paper ++ 2
8C1 pan-gH IgG2b Gill et al. (2006) 22
47-3D2 gL IgG3 This paper 22
47-5G10 gL IgM This paper 22
T7F5 gp150 IgG2a Gill et al. (2006) 22
3F7 gN IgG2a May et al. (2005) 22
MG-12B8 Capsid ORF65 IgG2a Gillet et al. (2006) 22
BH-6D3 Capsid ORF25 IgG1 Gaspar et al. (2008) 22
150-7D1 Capsid ORF17 IgG2a Gillet et al. (2007d) 22
MG-2C10 gB IgM Gillet et al. (2006) ++ ++
BN-6B5 gB IgM Gillet et al. (2008b) ++ +
BH-8F4 gB IgM Gillet et al. (2008b) ++ +
GB-7D2 gB IgG2a This paper + 2
T7H9 gB IgG2a Lopes et al. (2004) + 2
SC-9E8 gB IgG2a This paper +++ ++
MG-4D11 gB IgG2a Gillet et al. (2006) + 2
BN-1A7 gB IgG2a Gillet et al. (2008b) + 2
*Defined as a plaque-titre reduction of at least 50%, and graded arbitrarily as weak (+), medium (++) or strong (+++).
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virions better than wild-type virions. In Fig. 2(a), whilst
wild-type-immune serum neutralized gL
2 virions only
marginally better than wild-type virions, the result was
clearly different from that for gp70
2-immune serum,
which neutralized gL
2 virions less well than wild-type
virions. The difference was more obvious in Fig. 2(b),
where the ratios of serum to virus were lower. gp70-specific
antibodies therefore appeared to be a major reason for gL
2
virions being more susceptible to neutralization.
The converse was true, to a lesser degree, of gp70
2 virions:
they were neutralized poorly by gL
2-immune sera, which
lack antibodies to gH–gL. As MuHV-4 neutralization by
immuneseracorrelateswithablocktocellbinding(Gilletal.,
2006) and this requires either gp70 or gH–gL, but not both
(Gillet et al., 2008a), it was surprising that gL
2-immune and
gp70
2-immune sera still neutralized wild-type virions quite
well (Fig. 2a, b). This presumably reflects that immune sera
can also neutralize in other ways. For example, some mice
mount gB-specific neutralizing responses (Gillet et al.,2 0 0 6 ) .
Antibodies specific for abundant virion glycoproteins could
also hinder infection sterically. This would explain why gL
2-
immune sera neutralized wild-type virions better than they
neutralized gp70
2 virions: gp70 is normally highly abundant
andimmunogenic(Gilletetal.,2007b),butwouldbemissing
from gp70
2 virions.
Immune sera neutralize gL
” virions poorly for
macrophage infection
Although immune sera block MuHV-4 fibroblast and
epithelial-cell infections quite well, they tend to enhance
dendritic-cell and macrophage infections via IgG Fc
receptors (Rosa et al., 2007). This reflects that Fc receptor
binding allows opsonized virions to bypass blocks to
conventional cell binding. The infection enhancement
depends mainly on antibodies to gp150 (Gillet et al.,
2007b); the chief inhibitory antibodies recognize gH–gL
(Gillet et al., 2007d).
The greater gL
2 virus neutralization observed for BHK-21
fibroblasts did not apply to RAW-264 macrophages
(Fig. 2b). Very large amounts of immune serum reduced
wild-type infection, lower amounts increased it, gp70
2
virions were similar, and gL
2 virions showed marked
infection enhancement even at serum doses virtually
abolishing BHK-21 cell infection. The neutralization
Fig. 1. gL deficiency makes MuHV-4 vulnerable to neutralization
by immune serum. (a) Wild-type or gL
”STOP virions (100 p.f.u.)
were incubated (2 h, 37 6C) with sera from BALB/c mice infected
6 months earlier with wild-type MuHV-4. The virus/serum mixtures
were then plaque-assayed on BHK-21 cells. Titres are expressed
relative to virus without antibody. By scoring each virus as more
than or less than the mean titre of both at each serum dilution and
performing a x
2 test on all data points, gL disruption was found to
increase neutralization significantly (P,0.05). Three more serum
pools all gave the same result. (b) gL
+ (wild-type, gL
”DEL-STOP
revertant) and gL
” (gL
”DEL-STOP, gL
”STOP) virions (100 p.f.u.)
were incubated (2 h, 37 6C) with immune sera from C57BL/6
mice infected 6 months earlier with wild-type MuHV-4, then
plaque-assayed on BHK-21 cells. Titres are expressed relative to
virus without antibody, as in (a). Both gL
” viruses were neutralized
significantly better than either gL
+ virus (P,0.05). (c) Wild-type
and gL
” virions (100 p.f.u.) were incubated with sera from BALB/c
mice infected 9 months earlier with either wild-type or gL
” MuHV-
4, then plaque-assayed on BHK-21 cells. Titres are expressed
relative to virus without antibody. The gL
” virus was neutralized
significantly better than gL
+ for both sera (P,0.05). Two more
serum pools both gave the same result.
Gammaherpesvirus neutralization
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2-immune and gp70
2-immune sera
for different virions were also greatly reduced with RAW-
264 cells. These data indicated further that the strong
neutralization of gL
2 virions for BHK-21 cell infection by
wild-type-immune and gL
2-immune sera reflected mainly
a better block of cell binding.
The striking enhancement of gL
2 RAW-264 cell infection
by immune sera should not be overinterpreted. gL
2 viruses
showed capsid protein:p.f.u. ratios approximately 3-fold
higher than for gL
+ (Fig. 2c), i.e. gL
2 viruses were 3-fold
less infectious by plaque assay. gL
2 and gL
+ virus eGFP
+
titres were proportionate to their plaque titres. Therefore,
Fig. 2. The greater neutralization of gL
” virions depends mainly on antibodies to gp70. (a) EGFP
+ wild-type, gL
” (gL
”DEL-
STOP) and gp70
” virions (100 p.f.u.) were incubated (2 h, 37 6C) with sera from C57BL/6 mice infected 3 months before with
wild-type, gL
” or gp70
” MuHV-4, then plaque-assayed on BHK-21 cells. Titres are expressed relative to virus without antibody.
Two further experiments gave equivalent results. (b) In a similar experiment to (a), the virus/serum mixtures were split between
BHK-21 cells and RAW-264 cells, and infection was measured by flow cytometry of eGFP
+ expression 24 h later. Note that
the eGFP-based assay requires more virus, so the p.f.u. (ml serum)
”1 for each virus is 100 times higher in (b) than in (a). Each
point shows the result for 10
4 cells. Every visible difference between viruses or sera at each dilution was statistically significant
by Student’s t-test (P,0.001). Three further experiments gave equivalent results. The data are grouped by virus to allow
comparison with naive sera. However, all the data are from one experiment and are therefore directly comparable. Thus, it can be
seen that gL
” serum neutralized gL
”.wild-type.gp70
” virus for BHK-21 cell infection. (c) gL
” and gL
+ virus stocks were
compared for ORF17 virus capsid content per p.f.u. by immunoblotting.
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2 virions showed approximately 3-fold less infectivity for
RAW-264 cells without antibody than did gL
+ virions. The
main gL-dependent infection deficits are reduced binding to
BHK-21 cells (Gillet et al., 2007c) and premature membrane
fusion in NMuMG cells (Gillet et al., 2008c). Opsonization
would overcome any macrophage-binding deficit and could
alleviate any premature membrane fusion by diverting
virions into different endosomes. Such effects would restore
gL
2 infectivity back towards wild-type levels. Thus, it is
difficult to compare degrees of gL
+ and gL
2 infection
enhancement. Our conclusion from RAW-264 cell infec-
tions was simply that gL
+ and gL
2 virions showed much
less difference in neutralization when their dependence on
heparan sulfate for cell binding was reduced.
gL
” virion neutralization maps to the gp70 N-
terminal domains
Immune sera contain complex mixtures of immunoglobu-
lin specificities and isotypes. We therefore used mAbs to
define gp70-directed gL
2 virion neutralization more
precisely (Fig. 3a; Table 1). gp70 comprises four short
consensus repeats (SCRs 1–4) and an S/T-rich cytoplasmic
domain (Kapadia et al., 1999). As with the homologous
protein of the Kaposi’s sarcoma-associated herpesvirus
(Mark et al., 2006), heparan sulfate binding maps to gp70
SCRs 1–2 (Gillet et al., 2007a). We identified mAb-
recognition sites on gp70 by staining cells transfected with
membrane-anchored gp70 C-terminal truncation mutants,
as described previously (Gillet et al., 2007a). The most
effective gL
2-virus-neutralizing mAb, LT-6E8, recognized
SCR2; T2B11 and T1G10, which also neutralized, recog-
nized SCR1; mAbs specific for SCRs 3–4 did not neutralize
(Fig. 3a). gp70-directed neutralization therefore mapped to
the same domains as heparan sulfate binding.
Fig. 3. Neutralization of gL
+ and gL
” virions by gp70-specific
mAbs. (a) EGFP
+ wild-type (WT) and gL
”DEL-STOP (gL
”) virions
were incubated with mAbs specific for gp70 domains SCR1,
SCR2, SCR3 or SCR4. Each virus/antibody mixture was then split
between BHK-21 cells and RAW-264 cells. Infection was assayed
24 h later by flow cytometry of viral eGFP expression and is
expressed relative to virus alone. Each mAb is representative of at
least two recognizing the same domain. (b) An Fc fusion of gp70
domains SCR1+SCR2 was incubated with heparin, immune
serum (50 ml) or mAbs (100 mg), then used to stain NMuMG cells.
The dashed lines show staining with no Fc fusion or with the Fc
fusion protein alone. Each bar shows the median (±standard error
of the median) fluorescence intensity for 1000 cells. Each visible
difference between fluorescence intensities was statistically
significant by Student’s t-test (P,0.001). (c) eGFP
+ wild-type
(WT) and gL
”DEL-STOP (gL
”) virions were incubated with mAbs
specific for the heparan sulfate-binding sites of gH–gL (230-4A2)
and gp70 (LT-6E8), then split between BHK-21 cells and RAW-
264 cells. Infection was assayed 24 h later by flow cytometry of
viral eGFP expression and is expressed relative to infection with
virus alone. Each visible difference between antibodies at each
dilution was statistically significant by Student’s t-test (P,0.001).
Gammaherpesvirus neutralization
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contain the gp70 heparan sulfate-binding site (Gillet et al.,
2007a). LT-6E8 was also effective (Fig. 3b). A fusion of SCR
domains 1 and 2 was used here. LT-6E8 also blocked cell
binding by SCR1–2–3–Fc and SCR1–2–3–4–Fc (data not
shown). Inhibition of SCR1–2–Fc binding by soluble
heparin is shown for comparison. Immune sera caused
some non-specific inhibition of cell binding, but wild-type-
immune and gL
2-immune sera were clearly more effective
than gp70
2-immune or naive sera. Surprisingly, mAb
T1G10 failed to block SCR1–2–Fc cell binding even though
it neutralized gL
2 virions. Its epitope may have a different
relationship to the heparan sulfate-binding site between the
Fc-linked and virion forms of gp70. Overall, gp70-directed
neutralization appeared to target either heparan sulfate
binding or a very closely linked function.
No gp70-specific IgG mAb blocked RAW-264 cell infection
by gL
2 virions (Fig. 3a). This was again consistent with
gp70-directed neutralization blocking cell binding, and
therefore being unable to block infection when IgG Fc
receptors provided an alternative binding route. In
contrast, the gp70-specific IgM mAb T2B11 inhibits
RAW-264 infection by wild-type MuHV-4 moderately
(Rosa et al., 2007), presumably because its bulk causes
steric hindrance and RAW-264 cells lack high-affinity Fc m
binding. gp70-specific IgGs generally enhanced gL
+ RAW-
264 cell infection better than gL
2 RAW-264 cell infection.
Interestingly, SCR1/2-specific IgGs gave the best enhance-
ment. Such antibodies may mimic the orientation of
normal ligand binding and so optimally recruit the virion
fusion machinery.
We then tested neutralization by mAb LT-6E8 in
combination with mAb 230-4A2 (Gillet et al., 2008a),
which blocks heparan sulfate binding by gH–gL–Fc (Fig.
3c). LT-6E8 only inhibited wild-type MuHV-4 infection of
BHK-21 cells when combined with 230-4A2. 230-4A2
alone inhibited moderately, presumably because it also
stabilizes gH–gL to inhibit membrane fusion; it was much
more inhibitory when combined with LT-6E8 to block
heparan sulfate binding by both gH–gL and gp70. RAW-
264 cell infection resisted this inhibition. Thus, mAbs LT-
6E8 and 230-4A2 recapitulated the hierarchical effects of
immune sera (Fig. 2): 230-4A2 was analogous to gp70
2-
immune sera (no LT-6E8-type response), LT-6E8 to gL
2-
immune sera (no 230-4A2-type response) and both mAbs
together to wild-type-immune sera. These data further
supported the idea that immune sera inhibit fibroblast
infection mainly by blocking heparan sulfate binding.
gH-only is a neutralization target on gL
” virions
Although the major neutralization difference between gL
+
and gL
2 virions mapped to heparan sulfate binding by
gp70, this did not rule out other additional effects. In
particular, the vulnerability of fibroblast infection to cell-
binding blocks and the complexities of RAW-264 cell
infection by opsonized gL
+ and gL
2 virions would have
made post-binding inhibitions by immune sera hard to
identify. We therefore explored gL-dependent neutraliza-
tion further by testing mAbs from MuHV-4-infected mice
for preferential neutralization of gL
2 virions. We identified
five mAbs: four were equivalent to LT-6E8, recognizing
gp70, and were therefore not analysed further. However,
LT-5D3 (Fig. 4a, b) recognized gH-only, the gH antigenic
form expressed by gL
2 virions (Gillet et al., 2007c). Other
gH-only specific mAbs also neutralized gL
2 virions
(Fig. 4c). They enhanced gL
2 virus infection of RAW-
264 cells at low doses and inhibited it, albeit weakly, at high
doses (Fig. 4d), a pattern similar to that of gH–gL-specific
mAbs with wild-type virions (Gillet et al., 2007d).
gH–gL-directed neutralization of wild-type virions occurs
after binding (Gill et al., 2006). This was apparent from
staining cells for ORF25 major capsid antigen with mAb
BH-6D3. Fig. 5(a) shows NMuMG cell entry by non-
neutralized gL
+ and gL
2 virions, with gN co-staining for
comparison. Incoming gL
+ virion capsids migrated to the
nuclear margin, whereas gL
2 capsids remained scattered in
the cytoplasm (Gillet et al., 2008c). Note that BH-6D3
stains both perinuclear capsids and those still in intact
virions at the cell surface. Pre-treating gL
+ virions with
mAb T2C12 (gH–gL-directed neutralization) blocked the
accumulation of perinuclear capsids (Fig. 5b). Virions were
still endocytosed, but membrane fusion was presumably
blocked (Gill et al., 2006). Neither 8C1 (pan-gH, non-
neutralizing) nor MG-4A12 (gH-only) inhibited gL
+
capsid transport. gL
2 neutralization was more difficult to
analyse because gL
2 capsids do not migrate to the nuclear
margin. However, the MG-4A12 infection block clearly
occurred after virion binding and endocytosis. Such a block
was consistent with gH-only normally appearing only after
endocytosis, with gH–Fc showing no detectable cell
binding (Gillet et al., 2008a) and with gH-only-specific
mAbs inhibiting RAW-264 cell as well as BHK-21 cell
infections (Fig. 4c).
gL
” virions are vulnerable to gB-directed
neutralization
Although none of the mAbs selected for preferential gL
2
virion neutralization recognized gB, such a specificity could
easily have been missed, as few BALB/c mice make good
gB-directed neutralizing responses (Gillet et al., 2006).
Several established gB-specific mAbs showed gL-dependent
neutralization (Fig. 6a, b). Indeed, only MG-2C10, an IgM
that binds to the gB N terminus (Gillet et al., 2006),
neutralized gL
2 and gL
+ virions similarly. BN-6B5, which
recognizes a distinct epitope (Gillet et al., 2008b), was
substantially more effective against gL
2 virions (Fig. 6a).
BN-1A7, an IgG2a mAb whose epitope overlaps that of BN-
6B5, did not neutralize wild-type virions, but had some
effect against gL
2. SC-9E8, which recognizes a different
epitope in the N-terminal half of gB, was 10-fold more
effective against gL
2 virions than against gL
+. mAb T7H9
(Fig. 6b) recognizes an epitope just C-terminal to that of
L. Gillet and others
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been mapped; MG-4D11 recognizes the C-terminal half of
gB (Gillet et al., 2006). All of these mAbs, as well as 10
others with unmapped gB epitopes, neutralized gL
2 virions
better than gL
+. Thus, gL
2 virions were vulnerable to gB-
directed neutralization across multiple sites. This was due
Fig. 4. gL
” virus neutralization by mAbs specific for gH. (a) The specificity of mAb LT-5D3 was determined by flow cytometry of
BHK-21 cells either uninfected (UI) or infected with wild-type (WT) (2 p.f.u. per cell, 18 h) or gL
”DEL-STOP (gL
”) (2 p.f.u. per
cell, 48 h) viruses. We used different infection timings to equalize glycoprotein expression, as the cell-binding deficit of gL
”
virions makes their cell-surface glycoprotein expression lower for a given level of infection. The background fluorescence (nil)
was consequently somewhat higher for the gL
” infection. mAbs 8C1 and 8F10 provide staining controls. We also stained CHO
cells expressing a GPI-linked gH extracellular domain without gL. CHO cells expressing gp70 and the gp70-specific mAb LT-
6E8 provided staining controls. (b) eGFP
+ wild-type or gL
”DEL-STOP virions were mixed with mAb LT-5D3 (2 h, 37 6C), then
added to BHK-21 cell monolayers. eGFP expression was assayed 18 h later by flow cytometry of 10
4 cells. (c) gL
+ or gL
”
virions (100 p.f.u.) were incubated (2 h, 37 6C) with mAbs against gH–gL (T7G7, 7E5) or gH-only (MG-1A2, MG-2E6), then
used to infect BHK-21 cells. Plaque titres are expressed relative to those with virus and no antibody. gH–gL-specific mAbs
neutralized gL
+ virions significantly, but not gL
”, and vice versa for gH-only-specific mAbs. The data are from one of three
equivalent experiments. (d) eGFP
+ wild-type and gL
”DEL-STOP virions were incubated with gH-only-specific mAbs (MG-
9B10, MG-9A3) or a non-neutralizing gp150-specific control (T7F5), then split between BHK-21, NMuMG and RAW-264
cells. Viral eGFP expression was assayed by flow cytometry 24 h later, and is expressed relative to virus-only controls. The
dashed line for RAW-264 cells shows this as 100%.
Gammaherpesvirus neutralization
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2 virions containing less gB, nor to a
conformational difference in gB (Gillet et al., 2007c).
gL itself does not appear to be a significant
neutralization target
The MuHV-4 gL is small – approximately 19 kDa – and
probably lies close to the virion membrane (Gill et al.,
2006). It is therefore unlikely to be easily accessible. We
derived two gL-specific mAbs. Both stained 293T cells
transfected with a membrane-anchored form of gL (Fig.
7a) and stained BHK-21 cells infected with wild-type but
not gL
2 MuHV-4 (Fig. 7b). Immunofluorescence of
infected NMuMG cells showed gL expression in a
distribution consistent with the endoplasmic reticulum
(Fig. 7c). Our gL-specific mAbs neutralized neither wild-
type nor gp70
2 virions. Fig. 7(d) shows representative data.
Also, they did not block cell binding by gH–gL–Fc (data
not shown). These results were consistent with gL contrib-
uting to cell binding and membrane fusion only via gH.
DISCUSSION
gL is a small but important component of the herpesvirus
entry machinery (Roop et al., 1993). The MuHV-4 gL folds
gH for heparan sulfate binding (Gill et al., 2006), then
dissociates from gH after endocytosis to allow membrane
fusion (Gillet et al., 2008c). Both cell binding and
membrane fusion are potential neutralization targets, and
gL substantially influenced the fate of antibody-exposed
Fig. 5. gH-directed virus neutralization visualized by immunofluorescence. (a) NMuMG cells were incubated with wild-type or
gL
”DEL virions (2 h, 4 6C), washed with PBS, incubated further at 37 6C for the times indicated, then fixed, permeabilized and
stained for ORF25 (capsid) and gN. Each image is representative of .80% of the cells examined (n.100). (b) The same assay
was applied to gL
+ (wild-type, gL
+DEL-revertant) and gL
” (gL
”DEL, gL
”DEL-STOP) virions preincubated (2 h, 37 6C) with
mAbs T2C12, 8C1 or MG-4A12 or with no antibody (nil). The cells were incubated with virion–antibody complexes (2 h, 4 6C),
washed with PBS, incubated further to allow endocytosis (2 h, 37 6C), then fixed and stained for ORF25.
Fig. 6. gB-directed neutralization of gL
” and gL
+ MuHV-4. (a) EGFP
+ wild-type or gL
”DEL-STOP virions were incubated with
gB-specific mAbs (2 h, 37 6C) then added to BHK-21 cell monolayers. The cells were assayed for viral eGFP expression by
flow cytometry 18 h later. Each value (10
4 cells) is expressed relative to the no-antibody control. All visible differences between
viruses at each antibody dilution were statistically significant by Student’s t-test (P,0.001). (b) The same assay was applied to
more gB-specific mAbs.
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blocking the heparan sulfate interaction of gp70 blocked
the binding of gL
2 but not gL
+ virions. Therefore, a
possible explanation for the redundancy of MuHV-4
heparan sulfate binding – something common to many
herpesviruses – is antibody evasion.
Disrupting gL also made the gH-only conformation of gH
a neutralization target. This supported the idea that gH-
only, although downstream of gH–gL, is still pre-fusion
(Gillet et al., 2008c). Thus, gL limits gH-directed
neutralization to inhibiting the gH–gL to gH-only
transition. Antibody binding to gL-dependent gH epitopes
or compound gL–gH epitopes would stabilize gH–gL.
Antibodies specific for gL alone are unlikely to neutralize
unless gL also changes its conformation significantly when
it dissociates from gH. The recognition of both virus-
infected cells and recombinant gL by our gL-specific mAbs
implied that it does not. Accordingly, they did not
neutralize.
Finally, gL disruption made multiple gB epitopes better
neutralization targets. This presumably reflected the same
molecular events as the previously observed gL-dependent
conformational instability of gB (Gillet et al., 2008c).
However, the gB on extracellular gL
2 virions is conforma-
tionally normal – its instability manifests only after
endocytosis (Gillet et al., 2008c), and gL
2 virions were
Fig. 7. No significant neutralization by gL-specific mAbs. (a) mAbs were used to stain 293T cells either untransfected (UT) or
transfected with GPI-linked forms of gH, gL or gH–gL (gHL). (b) BHK-21 cells were left uninfected (UI) or infected with wild-
type (gL
+) MuHV-4 for 18 h or gL
”DEL-STOP (gL
”) MuHV-4 for 48 h. As in Fig. 4(a), different timings were used to equalize
the glycoprotein expression of the gL
” and gL
+ infections, giving slightly higher autofluorescence for gL
”. (c) NMuMG cells
were infected with gM–eGFP
+ MuHV-4 (2 p.f.u. per cell, 18 h), then fixed, permeabilized and stained (red) for capsid (ORF65,
mAb MG-12B8), gH-only (mAb MG-9B10), gH–gL (mAb T2C12) or gL (mAb 47-5G10). gM–eGFP appears green. Nuclei
were counterstained with DAPI (blue). Red–green colocalization appears yellow. (d) Wild-type, gL
”DEL-STOP (gL
”) and
gp70
” viruses (100 p.f.u.) were incubated with mAbs, then plaque-assayed on BHK-21 cells. Titres are expressed relative to
no-antibody controls.
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also recognizing gL
+ virions. Therefore the greater
vulnerability of gL
2 virions to gB-directed neutralization
appeared to reflect a greater exposure of its normal, pre-
fusion form.
Several lines of evidence indicate that disrupting gL
destabilizes gB by abolishing an extracellular interaction
between gB and gH–gL. First, the gH–gL and gB
extracellular domains are both unstable when expressed
alone, gH–gL becoming gH-only (Gillet et al., 2008a) and
gB adopting mainly its post-fusion form (Gillet et al.,
2008b). Second, gH–gL associates with gB and, although
their strongest link is probably intra-membrane (Gillet &
Stevenson, 2007a), it is hard to envisage how their
extracellular domains could avoid being associated too.
Third, the gB N terminus hides and so presumably contacts
part of gH–gL (Gillet & Stevenson, 2007b). As gB is
trimeric (Heldwein et al., 2006), each gB spike could
contact three copies of gH–gL; if gH–gL were also
multimeric, a two-dimensional lattice could form, and
such clustering would allow gH–gL to hide an appreciable
portion of gB. gL dissociation would then prime virions for
fusion by both changing gH and revealing gB. Normally
this would happen in late endosomes. A lack of gL would
trigger it sooner, making pre-fusion gB accessible to
antibody. Such a model would explain why most gB-
specific mAbs that neutralize wild-type virions are IgMs
(Gillet et al., 2008b): wild-type virions express some gH-
only (Gillet et al., 2007c), implying that some gB is
accessible; IgMs could bind one or two vulnerable gBs
extracellularly, then use their remaining arms to bind
newly revealed gBs in late endosomes.
A complete definition of MuHV-4 entry awaits gB–gH–gL
and gB–gH crystal structures, but already some points seem
clear. First, the gH–gL–gB composite presents epitopes
from both gB and gH–gL. The gH–gL heparan sulfate-
binding site defined by mAb 230-4A2 is not made more
accessible by deleting the gB N terminus (Gillet &
Stevenson, 2007b), and the N-terminal gB epitope defined
by MG-2C10 was not revealed better by deleting gL. These
must therefore be surface features. Second, when gL is lost,
multiple epitopes on both gB and gH–gL are revealed,
indicating a large-scale change. Third, the partial availabil-
ity of these epitopes on wild-type virions implies that not
all entry complexes are the same, perhaps because not all
gH is bound to gL.
What are the implications for neutralization-based vac-
cines? As immunodominant viral antigens work against
neutralization (Gillet et al., 2007b), one priority is to
identify minimal expression systems for key epitopes. An
example is gH and gL fused together, which stably present
native gH–gL epitopes (Gillet et al., 2007d). gB-specific
neutralizing IgMs are probably an unrealistic vaccine goal.
However, reconstitution of the epitope of SC-9E8, a
neutralizing IgG, may allow a similar approach with gB.
Our increasing understanding of MuHV-4 entry makes it a
suitable model to test the value of neutralization in a
persistent infection.
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